Reid Hoffman on AI impact on workforce
From Why the Co-Founder of LinkedIn Is Betting on NFTs Again · · CoinDesk
“The real business sustaining business advantage is not going to be a cost advantage. Namely, oh, you know, you you have 10 engineers and now I can do three. It's how do I use it for go to market, product development, iteration for for customers, depth of of tech stack. ... I actually think that what we've see I've seen so far and every company said, I'm doing layoffs because of AI, maybe other than Meta, right? Is um is not out of productivity, but is just out of reshifting like, oh, we've over-hired because of the pandemic.”
On , Reid Hoffman, Co-Founder at LinkedIn, spoke about AI impact on workforce during Why the Co-Founder of LinkedIn Is Betting on NFTs Again on CoinDesk.
About Reid Hoffman
Reid Hoffman, co-founder of LinkedIn and a partner at Greylock, has been making public appearances discussing artificial intelligence, cryptocurrency, and healthcare. At the Consensus 2026 conference, Hoffman stated that he bought his first Bitcoin in 2014 and has not sold any since, and he argued that as AI agents outnumber people on the internet, crypto becomes necessary for trust and identity. He said he has returned to crypto with "fresh conviction" and mentioned purchasing a CryptoPunk. At WIRED Health, Hoffman said that if a patient or doctor is not using frontier AI models as a second opinion for serious conditions, he believes they are "bordering on committing malpractice." He also expressed hope that within ten years, every major disease will have target molecules that could make a serious difference. In other appearances, Hoffman discussed the future of work and AI. At the Science x AI Summit, he said that "no one should really be an individual contributor" and that people should instead be "a manager of agents." On the Prof G Markets podcast, he described the transition to an AI-driven economy as "challenging" and noted that it is faster than previous technological shifts. Hoffman also discussed his role as co-founder of Manas AI, an AI-driven drug discovery company, and reiterated his view that AI can expand human capability, a theme he explored in his book "Superagency."